July 2016

July 18, 2016, Boca Raton, FL — The Metabolic Medical Institute has exciting news for medical professionals. The Fellowship in Metabolic and Nutritional Medicine (FMNM), the most popular advanced medical education fellowship offered by MMI, has just been approved to offer CME credits for their online core courses, Modules I-VII. Each module has been approved by ACCME for AMA PRA Category 1 Credits™ as well as continuing nursing education by ANCC and continuing pharmacy education from ACPE.

“Although we have been offering online education training for a number of years we were not meeting the increasing demand by our practitioners for online CME credits. Due to our collaboration with Global Education Group, we are pleased to now offer this option. It is always our goal to meet our health practitioners' expectations as they continue to dedicate endless hours to continuing education,” stated Doreen Brown, CEO of Metabolic Medical Institute.

Comprised of seven clinical modules and an eighth non-CME hands-on course, the Fellowship is an interactive educational experience that features advanced training and web broadcasts, teaching the knowledge and skills needed to effectively practice personalized, regenerative and functional medicine. This elite program includes the most current and relevant information pertinent to the prevention and treatment of disease including the latest findings in the areas of endocrinology, cardiology, neurology, nutrition and much more.

The curriculum which has been approved for Master’s Degree credits at both the George Washington University (GWU) and the University of South Florida (USF), is designed for progressive learning and is created by world-renowned experts from a variety of disciplines. The material stems from the root causes of chronic diseases that patients are affected by every day, offering a comprehensive approach for treating the patient, not just the symptoms.

It aims to prepare practitioners to become leaders in a new form of medicine, one that is personalized, preventive and predictive. Fellows learn a wellness-oriented approach to care, built on the latest breakthroughs in research across diverse medical and health care disciplines.

The Fellowship is truly a place for them to rediscover the passion for patient care. But most importantly, they can immediately begin to incorporate the teachings into their medical practice.

About MMI:

The goal of the Metabolic Medical Institute is to set a new standard of medical education, and to help practitioners better serve their patients, speaking a new language of health and wellness, fueled by the latest science. It is far better to prevent illness and build health than it is to treat disease when it has already taken hold. For more information, visit www.mmimedicine.com.

Contact:

Kacie Swid
Marketing Director
Tarsus Medical
1801 N. Military Trail, Suite 200
Boca Raton, FL  33431
561-997-0112 x7405
561-997-0287 (Fax)
k.swid@tarsusmedicalgroup.com
www.TarsusMedicalGroup.com

April 2016

In April 2016, the Endocrine Society published a scientific statement regarding compounded bioidentical hormones and their use in clinical practice. The Endocrine Society stated some things we could all agree upon: [1] the hormone physiology and pharmacology, and [2] the need to use a quality compounding pharmacy to provide the compounded drugs. The remainder of their “scientific statement,” was a combination of opinion, inaccurate facts and a plea to try and convince the readers (physicians) to use “FDA” approved drugs. Below is a commentary on some of the misstatements.

[1] “Compounded hormone medications are meant to be an alternative when an individual does not have access to or has an adverse reaction to a medication approved by the U.S. Food & Drug Administration”

  • Both the FDA and the United States Supreme Court agree that compounding is an important part of healthcare – not just as an alternative when FDA approved drugs are not available or tolerable, and there should be regulations and monitoring to assure patient safety. Thus, this statement: “compounded hormones are an alternative…” is an opinion not a true fact.
  • The FDA takes a very broad view of what compounding is, defining it as "a practice in which a licensed pharmacist, a licensed physician, …combines, mixes, or alters ingredients of a drug to create a medication tailored to the needs of an individual patient.” Isn’t that what medicine should be about, individualized care?
  • Additionally, in their raw form, ALL compounded hormones are FDA approved. Compounded hormones are individualized and not mass produced like FDA approved hormones, therefore, it is impractical if not impossible, to have every possible combination of compounded hormones go through the FDA approval process. The FDA and the United States Supreme Court agree!

 [2] “Compounded hormone medications can be unsafe when inappropriate practices are used”

  • This statement implies that compounded hormones are unsafe and FDA approved hormones are safe. Is “inappropriate practice” the teamwork that occurs between the patient, the physician and the compounding pharmacist to determine the right compound at the right dose for that particular patient?  If so, then Hippocrates got it wrong when he said: “It is more important to know what sort of person has a disease, than to know what sort of disease a person has.” The Endocrine Society writing group (“writing group”) would define appropriate practice as regardless of the patient’s needs, just prescribe a mass-produced fixed dose drug, thereby treating the disease, not the patient!
  •  Further, all drugs, including compounded drugs, need to be prescribed and monitored by a well-trained physician and compounded by a reputable pharmacy.
    • Physicians need to understand the risks and benefits of prescribing hormone therapy and be able to articulate these to the patient.
    • Safety risks can be minimized through the pharmacist’s knowledge and skill.
  • Under or over dosing is not unique to compounding pharmacies. Pharmaceutical companies, as opposed to compounding pharmacies, get to set their own potency windows. Compounding pharmacies have a 10% potency and reliability standard that must be met. However, reputable compounding pharmacies set their standards at ≤ 5%. We don’t know what the standards are for off the shelf, mass produced drugs including estrogens, progestins, testosterones, thyroid etc. Under or over dosing can occur with these drugs too. Since the Endocrine Society does not recommend monitoring, they would never know!
  • Additionally, the Endocrine Society pointed out the 2010 fungal meningitis that occurred in New England. However, they neglected to state that more than 100,000 individuals die each year from FDA approved prescription drug adverse reactions. The latter is the fourth leading cause of death in the United States.
  • Moreover, PremPro, an FDA approved drug, tested in the Women’s Health Initiative (WHI) increased cardiac events, strokes and breast cancer.  Whereas, to date, there has never been a BHRT related death.

 [3] “… widely available hormone treatments that are 100% chemically identical to the native hormones found in the body and FDA approved offer effective and safe options….etc.”  I don’t think so!

  • The only “chemically identical” FDA approved hormone options that are available are Prometrium and the Estradiol patch.  All other preparations are non-bioidentical ethinyl estradiol (found in OCP’s), synthetic progestins found in birth control pills, the Mirena IUD, and medroxyprogesterone acetate (found in PMP HRT).  Premarin is a non-human bioidentical hormone that is chemically identical to hormones found in horses.
  • Comparing and contrasting oral estrogens (typically not bioidentical) and bioidentical estrogens NOT orally administered:
    • Significantly different effects are seen between oral and transdermal/ subcutaneous (TD/SQ) administered estrogens. These differences may in part be related to route of administration, avoiding first-pass metabolism, thereby decreasing the amount of potentially toxic estrogen metabolites. TD/SQ estrogen doesn’t adversely affect inflammatory markers such as CRP, coagulation factors, and the fibrinolytic pathway, while oral estrogen can adversely alter these markers.
    • Also, oral estrogen therapy, as opposed to TD/SQ estrogen, is associated with increased risk of stroke, venous thromboembolism, pulmonary embolism, hypertension, gallbladder disease, metabolic syndrome, insulin resistance, liver cancer, and weight gain. Oral estrogens increase sex hormone binding globulin (SHBG), which can result in decreased testosterone bioavailability and can elevate liver enzymes, estrone, CRP, triglycerides, and matrix metalloproteinases. Oral estrogen decreases IGF-1 and growth hormone levels, and may impair conversion of T4 to T3.
  • Synthetic Progestins versus bioidentical Progesterone:
    • Synthetic progestins and bioidentical progesterone both exhibit endometrial protection when used in combination with estrogen, however, they differ in their chemical structures, metabolism, potency, steroid receptor affinity, intracellular mechanisms of action, and biological and clinical effects.
    • Synthetic progestins increase breast cell proliferation rates and are associated with increased rates of breast cancer. As opposed to micronized Progesterone which causes coronary vasodilation, synthetic progesterone increases coronary artery reactivity, endothelial damage and plaque formation, while worsening insulin resistance and decreasing HDL. Thus, synthetic progestins are associated with an increased risk of cardiovascular disease and acute MI.
    • As opposed to progestins, progesterone, acting as a neurosteroid, has neuroprotective effects on the brain and nervous system, while progestins (MPA) does not.
    • Allopregnanolone, the oral progesterone metabolite, modulates neuronal excitability, and potentiates GABA, thereby exhibiting anxiolytic, sedative, and anti-epileptic properties. Conversely, synthetic progestins are associated with increased depression and anxiety, and do not seem to improve quality of life in postmenopausal women as much as micronized progesterone.
    • Bioidentical progesterone is associated with a decreased risk of breast cancer, as compared to synthetic progestins, via various mechanisms. It inhibits estrogen stimulated breast cells; downregulates estrogen receptor alpha (ER-⍺ - the receptor associated with breast cell proliferation); increases the conversion of more potent estrogens into less potent estrogens, etc.
  • Regarding boosting testosterone levels in women, it is true that there are no FDA approved therapies using testosterone, however, observational studies mostly show an inverse relation between testosterone levels in women and cardiovascular risk, cardiovascular events, and all-cause mortality.
    • A 2014 study (Davis S, et al.) using physiologic exogenous transdermal testosterone replacement in postmenopausal women was associated with improved verbal learning and memory.
    • Low levels of testosterone in women are associated with lower bone mineral density, and a small study found estradiol and testosterone replacement in women significantly increased bone mineral density.
    • There is no obvious association with bioidentical testosterone replacement in females and the risk of ovarian or endometrial cancer, however, high androstenedione levels may be associated with some types of ovarian cancer, perhaps due to its conversion to estrone, thus emphasizing the need for monitoring, which the writing group does not support.
    • Compared to the use of methyltestosterone (oral – synthetic), bioidentical testosterone has not been shown to increase the risk of breast cancer.

[4] “LT4 is bioidentical and a highly effective and safe therapy and is the treatment of choice for hypothyroidism. The complex tissue-specific deiodinase system converts T4 to T3 and supplies the proper amount of T3 to each of thebody’s tissues according to its requirements.”

  • This statement contradicts their previous statement regarding “the preferable ratio of 14:1.” LT4 alone, typically does not obtain this desired ratio. However, the combination of LT4 and LT3 may obtain this ratio, if the patient’s required thyroid dosing fits within the mass produced available doses. However, most patients want, and need individualized dosing to assure “their” thyroid function is optimum. This typically can only be achieved by compounding.
  • Since the writing group uses TSH +/ T4 as its measuring stick, it is unclear how they would know whether or not a patient needs T3 as well as how much they need. They should heed their own advice: measure and monitor – complete thyroid hormones, not just select ones.

CONCLUSION

You have to know who you are dancing with before you get on the dance floor! This 2016 Endocrine Society statement was authored by six individuals, 4 of whom have financial relationships with large pharmaceutical companies. Thus, it’s easy to conclude they could have a conflict of interest and should not be the group writing a scientific statement comparing the use of bioidentical hormones and synthetic hormones in clinical practice. It is unfortunate that they are using this medium, writing as if they are the last and final word on the subject, when they are not, (see the recent Wall Street Journal Article – quoting a well-respected endocrinologist re: compounded thyroid) to try and convince physicians to use synthetic hormones, without appropriate monitoring, that increase morbidity and possibly mortality. As functional medicine physicians we know better. Thus, it is our responsibility to educate our peers and healthcare clients.

April 13, 2016 (Boca Raton, FL) - The Metabolic Medical Institute is extremely pleased to announce that the Fellowship in Integrative Medicine in partnership with the George Washington University has received approval by the American Board of Physician Specialties to qualify graduates to sit for the newly established American Board of Integrative Medicine® (ABOIM®). This inter-professional fellowship program is led by Dr. Andrew Heyman.

The Metabolic Medical Institute http://www.mmimedicine.com contributes expert faculty and content to the program, and is critical in person learning experiences for students. MMI is widely recognized as a leader in medical education in nutrition, metabolism, Functional and Integrative Medicine, and serves as the principal training partner to the George Washington University in Integrative Medicine.

The Metabolic Medical Institute continues to carry on its long-time mission to provide clinicians with advanced medical education that fosters disease prevention. Being at the forefront of medicine’s paradigm shift, we are proud of our partnership with George Washington University and achieving this very prestigious subspecialty of Integrative Medicine. Increasing the number of well trained, certified specialists in Integrative medicine will significantly provide access to better patient care. The acknowledgement of this subspecialty has an impact in the ability of the healthcare community to address chronic disease states with far reaching effects on patients, communities and society as a whole ’ said Doreen Brown, CEO, Tarsus Medical Group.

The Fellowship https://smhs.gwu.edu/integrative-medicine/about is the first academic program in the country that confers both a Masters in Science in Health Sciences in Integrative Medicine through a major university and allows physicians the opportunity to become Board Certified as well. The curriculum is a longitudinal, cross-disciplinary hybrid model comprised of on line, in person, scholarly and practical experiences.

Fellows generate patient care plans, conduct case analyses, and evaluate practice standards to demonstrate competence of integrative medicine practice. Biostatistics, epidemiology, and clinical research courses provide an opportunity for students to collaborate with professionals from various disciplines, explore translational research in human health and allow participation in practice-based research networks.

The Fellowship program ensures graduates will operate successful clinical practices, while building their professional skill set in research methods, business practices, relevant health policy and social aspects of health.

Dr. Heyman says, ‘I am delighted to direct such an innovative program in collaboration between two premier educational organizations such as MMI and GW. It represents an evolution in the field of medicine and our graduates will lead this change towards a more patient centric, wellness and health focused health care system. The assembled expert faculty, along with the depth and breadth of curriculum is at the highest academic level. Our approval for the new Board of Integrative Medicine demonstrates our collective commitment to excellence in education.’

June 2015

June 8, 2015 (Boca Raton, FL) - Tarsus Medical Group is pleased to announce the launch of the new Master of Science in Health Sciences in Integrative Medicine Degree Program at The George Washington University Department of Health Sciences in collaboration with Tarsus’s premier educational entity, Metabolic Medical Institute (MMI). The addition of the Master’s degree to the Tarsus Medical Group portfolio of professional education makes it the only private organization nationwide to offer practitioners interested in Integrative medicine a curriculum with fully accredited University support.

The Master of Science Degree Program totaling 30 academic credits establishes the importance of comprehensive, wellness-oriented health care, one that is pro-active, preventive and treats the ‘whole patient.’ With the announcement of its second university affiliation, MMI proves to hold quite a track record of offering premier medical education, and the collaboration with George Washington University ensures a continued high standard of learning experiences.

The shift to “personalized” and patient centered medicine has caused both physicians and allied health professionals to seek new and advanced methods to prevent disease, treat patients, and improve clinical outcomes in a challenging environment. This is evidenced by the recent 2013 approval of the American Board of Integrative Medicine (ABOIM) by the American Board of Physician Specialists (ABPS) for practitioners looking to include metabolic or integrative methods into their current practice. And, more recently the National Center for Complementary and Alternative Medicine (NCCAM) was renamed as the National Center for Complementary and Integrative Health (NCCIH) in 2014 per Presidential mandate.

In evaluating the increased market changes, as well as its total growth, MMI aims to help doctors become the intersection between healthcare, technology and a patient’s lifestyle. The lines between self-care, the physician and the marketplace have become blurred demanding new training, data collection and outcomes research to fuel the consumer directed prevention and treatment model. As technology is advancing and clinical methods now apply systems biology with deep personalized, preventive and proactive roots, the healthcare practitioner of the future must become an expert in many areas to succeed and thrive in the current competitive marketplace.

With this groundbreaking initiative, Tarsus Medical Group is taking the lead to meet these expectations by expanding educational programming, affiliating with prestigious academic institutions, aligning with expert faculty and key opinion leaders, and utilizing advanced educational methods. As the entity which houses all advanced medical education within the Tarsus Medical Group, MMI was designed to meet the educational needs of healthcare professionals in order to advance their knowledge and clinical skills in this environment. It is the only organization of its kind to do so with actual accredited educational University support as well as two Master’s Degree programs to offer physicians and healthcare practitioners.

The most instrumental individual in the creation of this Master’s Degree curriculum, Andrew Heyman, MD, the Director of Graduate Studies, Integrative Medicine at The George Washington University shares that “MMI is leading the way in changing healthcare by partnering with world class academic centers such as The George Washington University.  This collaboration represents the New Medicine, one that is preventive, pro-active and patient centered.  Our graduates will be recognized as the foremost experts in evidence-based Integrative medicine, and will be positioned to enter high level clinical, academic and policy roles in order to transform the medical system.  I have been in this field for over 25 years, and am delighted to finally see real progress at the institutional level, in order to return healing back into the center of health care." 

May 2015

May 21, 2015 (Boca Raton, FL) - Tarsus® is pleased to announce the exciting new addition of PAINWeek to its medical division, Tarsus Medical Group, which now has grown to a portfolio of five entities within the medical education and event industries. These include: the American Academy of Anti-Aging Medicine (A4M), Metabolic Medical Institute (MMI), the Cardiometabolic Health Congress (CMHC), the South Beach Symposium (SBS), and as of May 21, 2015, PAINWeek. The five entities provide a comprehensive, revolutionary collection of global events focused on valuable live and online medical educational programs for healthcare practitioners of various specialties. All entities provide clinical education focused on disease prevention and management while taking into account a rapidly changing health industry.

Tarsus Medical’s newest addition to its portfolio occurred this week and addresses the medical world’s recent interest with Pain Management and the vital concern surrounding the repercussions that come from the use of pain medications. PAINWeek, which was launched in 2007 as an inclusive education event in Las Vegas, is now in its 9th year and stands as the largest U.S. Pain Conference. It has grown to be considered the Pain Education Resource for all Frontline Practitioners. The PAINWeek communications platform spans live, digital and print communications representing a single resource for busy practitioners that will extend both the experience and energy from the national and regional conference throughout the year to a wider audience of frontline practitioners that have an interest in pain management. PAINWeek’s annual event will take place at the Cosmopolitan of Las Vegas on September 8-12, 2015 and expects to welcome physicians, nurses, pharmacists and other healthcare professionals for a comprehensive program of courses which will offer up to 120 hours of CME activities, satellite events, and exhibits.

Established in 1992, The American Academy of Anti-Aging Medicine (A4M) continues to be the leading not-for-profit medical society dedicated to the detection, prevention and treatment of age related diseases. The A4M is dedicated to educating physicians, scientists, and the public on biomedical sciences, breaking technologies, and preventative medicine issues. A4M is comprised of over 26,000 members from 120 nations worldwide including healthcare practitioners, scientists, researchers, and governmental officials. A4M provides two Board Certification tracks which include the American Board of Anti-Aging/ Regenerative Medicine (ABAARM) for physicians, and the American Board of Anti-Aging Health Practitioners (ABAAHP) for allied health professionals.

The A4M World Congresses held in both the spring in Florida and the winter in Las Vegas are highly attended live events showcasing presentations and specialty workshops hosted by prominent speakers from the anti-aging and aesthetic medical fields. Each of these events also host over 350 exhibitors. Additional A4M live conferences (U.S. and international) are also held throughout the year on medical topics such as Bio-Identical Hormone Replacement Therapy (BHRT), Gut/Brain Connection, Stress, IV Therapies and Aesthetics.

Debuting as the entity which houses advanced medical education within the Tarsus Medical Group, the mission of the Metabolic Medical Institute (MMI) is to meet the demand for premium evidence-based programs in metabolic, nutritional, functional, and integrative medicine for physicians and allied health professionals. With its portfolio of live and online courses, MMI offers the opportunity to earn advanced degrees from a variety of distinguished accredited universities. This includes an affiliation with The Morsani College of Medicine at The University of South Florida (USF) to provide Fellowships in Metabolic and Nutritional Medicine, Aesthetics, Stem Cell Therapy, and Integrative Cancer Treatment. MMI, in partnership with USF also offers various Certification programs as well as two Master’s programs in Medical Sciences. And, through its affiliation with The George Washington University, MMI offers both a Graduate Certificate and a Master’s Degree in Integrative Medicine for graduates.

There is an undisputable universal shift into more personalized medicine arising from advances in technology to detect genetic and metabolic predispositions to disease, the utility of these technologies by clinicians, and an increasing awareness by patients who request this type of clinical service. This shift along with the changing US healthcare landscape, both present new challenges and opportunities making collaboration increasingly necessary for success. Drug manufacturers, biotech, diagnostic and pharmaceutical companies, must all re-evaluate and develop ways to add value. In response to this, MMI offers academic and industry partnerships to support and provide advanced targeted educational programming on the forefront of clinical biomedical science implementing genomics and proteomics to preventatively assess and treat patients with relevant diseases or conditions. MMI was designed to meet the educational needs of healthcare professionals in order to advance their knowledge and clinical skills in this environment.

The acquisition of CMHC by Tarsus in early 2014 expanded the organization’s live and online medical education offerings to include events focused on the prevention and management of cardiometabolic diseases. The CMHC is the largest U.S. event in the cardiometabolic field and is attended by physicians including endocrinologists, cardiologists and primary care physicians, as well as allied health professionals such as nurse practitioners and physician assistants every October. The Best of Cardiometabolic Health Congress is being launched in 2015 as a Regional Conference series comprising of 3 one-day conferences in different locations around the U.S. This now provides a convenient way for clinicians to earn CME/CE credits while learning about current, new, and emerging therapies, treatment guidelines, and practical strategies to reduce cardiometabolic risk and improve patient outcomes from expert faculty.

In late 2014, Tarsus added the South Beach Symposium (SBS) to its medical division’s portfolio. SBS provides medical education to physicians and professional staff members of medical practices specializing in dermatology, plastic surgery, cosmetic surgery, pediatric dermatology and other dermatologic medical procedures. SBS holds its Annual Symposium as a live opportunity to educate practicing dermatologists about advances in clinical and aesthetic dermatology from nationally known dermatologic experts in various sub-specialty areas. The 5-day conference provides a comprehensive overview of the newest therapies and procedures through advanced educational sessions and live patient workshops. SBS provides attendees with transferable skills and related techniques that can quickly and easily be adapted to their current practice environment.

A key focus for the Tarsus Medical Group is to expand educational programming into Preventative and Integrative Medicine in a changing U.S. healthcare landscape. This parallels the shift towards personalized medicine, which continues to create new business models and opportunities within the healthcare industry that all parties, including doctors, will have to adapt to in order to stay competitive. Tarsus Medical’s goal is to create a platform of premier medical educational programs with groundbreaking curricula that is attractive to clinicians, industry sponsors, academic institutions, and other organizations. This is evidenced by the recent 2013 approval of the American Board of Integrative Medicine (ABOIM) by the American Board of Physician Specialists (ABPS) for practitioners looking to include metabolic or integrative methods into their current practice. And, more recently the National Center for Complementary and Alternative Medicine (NCCAM) was renamed as the National Center for Complementary and Integrative Health (NCCIH) in 2014 per Presidential mandate.

Due to the shift, physicians and allied health professionals are seeking new and advanced methods to prevent disease, treat patients, and improve clinical outcomes in a challenging environment. In evaluating the increased market changes, as well as its total growth, Tarsus aims to help doctors become the intersection between healthcare, technology and a patient’s lifestyle. Moreover, as technology is advancing and clinical methods now apply systems biology with deep personalized, preventive and proactive roots, the healthcare practitioner of the future must become an expert in many areas to succeed and thrive in a competitive marketplace. Tarsus Medical Group is taking the lead to meet these expectations by expanding educational programming, providing science-based information, affiliating with prestigious academic institutions, aligning with expert faculty and key opinion leaders, and utilizing advanced educational technologies. “Regardless of what they specialize in, physicians can turn to us for high quality education, innovative, interactive conferences in which they can network, and practice-changing protocols,” says Doreen Brown, CEO of the Tarsus Medical Division. “Bringing these entities together enables us to offer more value to our practitioners and empowers them to transform and strengthen their practices within a rapidly changing industry.”

April 2015

April 29, 2015 (Boca Raton, FL) - Tarsus® is pleased to announce its medical division, Tarsus Medical Group, which now consists of a portfolio of four entities within the medical education and conference industries. These include: the American Academy of Anti-Aging Medicine (A4M), Metabolic Medical Institute (MMI), the Cardiometabolic Health Congress (CMHC), and the South Beach Symposium (SBS). The four entities provide a comprehensive, revolutionary collection of global events focused on valuable live and online medical educational programs for healthcare practitioners of various specialties. All entities are geared at providing clinical education focused on disease prevention and management, taking into account a rapidly changing health industry.

Established in 1992, The American Academy of Anti-Aging Medicine (A4M) continues to be the leading not-for-profit medical society dedicated to the detection, prevention and treatment of age related diseases. The A4M is dedicated to educating physicians, scientists, and the public on biomedical sciences, breaking technologies, and preventative medicine issues. A4M is comprised of over 26,000 members from 120 nations worldwide including healthcare practitioners, scientists, researchers, and governmental officials. A4M provides two Board Certification tracks which include the American Board of Anti-Aging/ Regenerative Medicine (ABAARM) for physicians, and the American Board of Anti-Aging Health Practitioners (ABAAHP) for allied health professionals.

The A4M World Congresses held in both the spring in Florida and the winter in Las Vegas are highly attended live events showcasing presentations and specialty workshops hosted by prominent speakers from the anti-aging and aesthetic medical fields. Each of these events also host over 350 exhibitors. Additional A4M live conferences (U.S. and international) are also held throughout the year on medical topics such as Bio-Identical Hormone Replacement Therapy (BHRT), Gut/Brain Connection, Stress, IV Therapies and Aesthetics.

Debuting as the entity which houses advanced medical education within the Tarsus Medical Group, the mission of the Metabolic Medical Institute (MMI) is to meet the demand for premium evidence-based programs in metabolic, nutritional, functional, and integrative medicine for physicians and allied health professionals. With its portfolio of live and online courses, MMI offers the opportunity to earn advanced degrees from a variety of distinguished accredited universities. This includes an affiliation with The Morsani College of Medicine at The University of South Florida (USF) to provide Fellowships in Metabolic and Nutritional Medicine, Aesthetics, Stem Cell Therapy, and Integrative Cancer Treatment. MMI, in partnership with USF also offers various Certification programs as well as two Master’s programs in Medical Sciences. And, through its affiliation with The George Washington University, MMI offers both a Graduate Certificate and a Master’s Degree in Integrative Medicine for graduates.

There is an undisputable universal shift into more personalized medicine arising from advances in technology to detect genetic and metabolic predispositions to disease, the utility of these technologies by clinicians, and an increasing awareness by patients who request this type of clinical service. This shift along with the changing US healthcare landscape, both present new challenges and opportunities making collaboration increasingly necessary for success. Drug manufacturers, biotech, diagnostic and pharmaceutical companies, must all re-evaluate and develop ways to add value. In response to this, MMI offers academic and industry partnerships to support and provide advanced targeted educational programming on the forefront of clinical biomedical science implementing genomics and proteomics to preventatively assess and treat patients with relevant diseases or conditions. MMI was designed to meet the educational needs of healthcare professionals in order to advance their knowledge and clinical skills in this environment.

The acquisition of CMHC by Tarsus in early 2014 expanded the organization’s live and online medical education offerings to include events focused on the prevention and management of cardiometabolic diseases. The CMHC is the largest U.S. event in the cardiometabolic field and is attended by physicians including endocrinologists, cardiologists and primary care physicians, as well as allied health professionals such as nurse practitioners and physician assistants every October. The Best of Cardiometabolic Health Congress is being launched in 2015 as a Regional Conference series comprising of 3 one-day conferences in different locations around the U.S. This now provides a convenient way for clinicians to earn CME/CE credits while learning about current, new, and emerging therapies, treatment guidelines, and practical strategies to reduce cardiometabolic risk and improve patient outcomes from expert faculty.

In late 2014, Tarsus added the South Beach Symposium (SBS) to its medical division’s portfolio. SBS provides medical education to physicians and professional staff members of medical practices specializing in dermatology, plastic surgery, cosmetic surgery, pediatric dermatology and other dermatologic medical procedures. SBS holds its Annual Symposium as a live opportunity to educate practicing dermatologists about advances in clinical and aesthetic dermatology from nationally known dermatologic experts in various sub-specialty areas. The 5-day conference provides a comprehensive overview of the newest therapies and procedures through advanced educational sessions and live patient workshops. SBS provides attendees with transferable skills and related techniques that can quickly and easily be adapted to their current practice environment.

A key focus for the Tarsus Medical Group is to expand educational programming into Preventative and Integrative Medicine in a changing U.S. healthcare landscape. This parallels the shift towards personalized medicine, which continues to create new business models and opportunities within the healthcare industry that all parties, including doctors, will have to adapt to in order to stay competitive. Tarsus Medical’s goal is to create a platform of premier medical educational programs with groundbreaking curricula that is attractive to clinicians, industry sponsors, academic institutions, and other organizations. This is evidenced by the recent 2013 approval of the American Board of Integrative Medicine (ABOIM) by the American Board of Physician Specialists (ABPS) for practitioners looking to include metabolic or integrative methods into their current practice. And, more recently the National Center for Complementary and Alternative Medicine (NCCAM) was renamed as the National Center for Complementary and Integrative Health (NCCIH) in 2014 per Presidential mandate.

Due to the shift, physicians and allied health professionals are seeking new and advanced methods to prevent disease, treat patients, and improve clinical outcomes in a challenging environment. In evaluating the increased market changes, as well as its total growth, Tarsus aims to help doctors become the intersection between healthcare, technology and a patient’s lifestyle. Moreover, as technology is advancing and clinical methods now apply systems biology with deep personalized, preventive and proactive roots, the healthcare practitioner of the future must become an expert in many areas to succeed and thrive in a competitive marketplace. Tarsus Medical Group is taking the lead to meet these expectations by expanding educational programming, providing science-based information, affiliating with prestigious academic institutions, aligning with expert faculty and key opinion leaders, and utilizing advanced educational technologies. “Regardless of what they specialize in, physicians can turn to us for high quality education, innovative, interactive events in which they can network, and practice-changing protocols,” says Doreen Brown, CEO of the Tarsus Medical Division. “Bringing these entities together enables us to offer more value to our practitioners and empowers them to transform and strengthen their practices within a rapidly changing industry.”

November 2014

BOCA RATON, FL (Nov. 18, 2014)  - The Metabolic Medical Institute (MMI) was pleased to host several local medical students at its Live Integrative and Metabolic Medicine Courses in Miami, FL on October 31, 2014.

These courses are part of an Integrative Medicine Graduate Certificate program offered through MMI’s partnership with the George Washington University.   Students and seasoned practitioners alike mingled with, and learned from, some of the industry’s leading integrative medicine experts during this event.

Attendees gained an understanding of how integrative medicine offers a very different approach to the present standard of care, as it seeks to treat the root causes of disease and illness, rather than simply manage the symptoms. 

“This conference gave me a whole new perspective on the field of medicine.” said a University of Miami medical student. “I learned to focus on health and healing, as opposed to disease management. I couldn't believe how much scientific evidence there was behind the integrative therapies.”

In-depth sessions at the event were led by specialists who revealed how factors like hormones, nutrients and toxins play a central role in common diseases, and each shared effective, research-based approaches for patient treatment.   

Jeff Peterson, a first year MD/PhD student at the University Of Miami Miller School Of Medicine, said he was “absolutely blown away” by what he heard.  “It was amazing that a current standard of care in psychiatry, a prescribed anti-depressant, had less scientific support in its efficacy than a high dose of B12. I also didn't realize the acute degree to which diseases are interrelated by inflammation.”

Once dismissed, integrative medicine is gaining ground as significant scientific evidence is demonstrates successful patient outcomes.  The combination of conventional and integrative approaches enables physicians to consider all the possible factors and influences to disease, and builds a more collaborative partnership between patient and practitioner during the healing process.

 “Although I have been extremely pleased with my medical education, I haven't learned much in the fields of nutrition, exercise, and other evidence based forms of healing,” shared one student attendee.  “This event was extremely informative and really helped to round out my medical education.”

With the recent changes in healthcare policies, many medical students and young physicians face uncertainty about the industry.   MMI’s events are geared to provide today’s physicians, both seasoned and new, with high-quality education, world-renown speakers, innovative approaches, and scientific research to help them be more proactive, and more successful within the ever-changing medical landscape.  MMI is taking an influential step to impact the future of medicine by providing students with access to relevant, timely information that they can use with their patients immediately upon entering the field. 

“As a medical student interested in this field, I have been to a number of similar events over the past few years. I can honestly say that the MMI conference was by far the most well organized, inspiring and informative conference I have ever been to. The knowledge I gained and connections I made have already made a huge impact in my medical education, and future career.”

BOCA RATON, FL (Nov. 5, 2014) - Medical professionals from all over the nation gathered at The Fontainebleau Hotel this weekend for The Metabolic Medical Institute’s (MMI) Integrative and Metabolic Medicine Courses.  

The event offered an invaluable forum for practitioners to network, learn and share the latest studies and insights in integrative and functional medicine.  Kicking off on Friday October 31st, the event featured two concurrent and comprehensive 3-day courses, and allowed practitioners the opportunity to earn up to 24 CME credits at one of Miami’s most beautiful venues.  

Course III focused on Nutritional Metabolism, Environmental Exposures, Cardiometabolic Diseases and Hormone Management.  Leading integrative medicine experts, such as George Bakris, MD, Russell Jaffe, MD, PhD, and Joel Heidelbaugh, MD, led sessions on the assessment and management of cardiometabolic risk, hormonal imbalances, bioidentical hormone replacement therapy, and medical toxicology and detoxification strategies.  Practitioners were provided comprehensive information on how factors like hormones, nutrients and toxins play a central role in common cardiac and endocrine disease.

Well-known physicians and scientists, including  Alessio Fasano, MD, Kelly Brogan, MD, and Ritchie Shoemaker, MD,  led discussions for Course IV which focused on Gastroenterology, Immunology, and Neurology.  These sessions enabled practitioners to better assess and recognize disease markers, and develop personalized integrative treatment plans.  Key topics included the effective assessment and management of gastrointestinal disorders, management of patients with cancer and chronic infections, and integrative strategies for treating neurologic and psychiatric conditions.

"After four years of Graduate School at UCLA and two residencies, followed by over thirty years of practice, I was faced with a gnawing frustration due to the lack of scientific extent in the practice of medicine,” shared Douglas Beatty, MD.   “Finally deciding to take the plunge into MMI was an absolutely revolutionary experience with an explosion of scientific data presented by world renowned scientists and clinicians whose articles I have read for years.  This one course this weekend has given me hope to master the molecular and integrative specialty, which has been my passion from the start." 

The courses are an integral part of the Graduate Certificate in Integrative Medicine offered through MMI’s educational partnership with The George Washington University School of Medicine and Health. MMI formed an alliance with The George Washington University earlier this year to provide medical practitioners with a more robust portfolio of educational offerings, supported by one of the top universities in the country.  

The program is directed by Andrew Heyman MD MHSA, an internationally recognized expert in Integrative Medicine.  Prior to assuming this role, Dr. Heyman spent sixteen years at the University of Michigan, building one of the largest and most successful academic-based Integrative Medicine programs in the United States.  
 
Attendees at this weekend’s event certainly found it to be valuable, relevant, enlightening, and an important investment in transforming their practice, and improving patient care.
 
“What I found particularly useful was the diversity of speakers,” said Dr. Susan Marra, a naturopathic physician from Washington.  “Since my patients suffer from a myriad of complex chronic illness for which I hope to help them heal from, I am always in search of new ideas and perspectives to help me move them along their healing journey.  It's like a Rubik’s cube, for which I have been using a set way to problem solve.  MMI has given me a new perspective.”

Educationally Partnered With

USF Logo A4M LogoWashington Logo
White Bottom Arrow